Analysis of the Oncogenic Role of Methyltransferase Like 3 (METLL3) in Head and Neck Squamous Cell Carcinoma (HNSCC)

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. 1METTL3 as a potential predictive biomarker for immunotherapy response in metastatic head and neck cancer.2024
2. 2Association between methyltransferase-like 3 and non-small cell lung cancer: pathogenesis, therapeutic resistance, and clinical applications2024 · 11 citations
3. 3The two-faced role of RNA methyltransferase METTL3 on cellular response to cisplatin in head and neck squamous cell carcinoma in vitro model2024 · 4 citations
4. 4The Prognostic and Predictive Value of METTL3 in Metastatic Colorectal Cancer2026
5. 5The novel <scp>m6A</scp> writer methyltransferase 5 is a promising prognostic biomarker and associated with immune cell infiltration in oral squamous cell carcinoma2024 · 13 citations